Dexamethasone Treatment Has No Effect on the Formation of Pneumococcal Antibodies during Community-Acquired Pneumonia | Zendy

Suzan P. van Mens | Zendy; Sabine C A Meijvis | Zendy; Jan C. Grutters | Zendy; Bart J. M. Vlaminckx | Zendy; Willem Jan W. Bos | Zendy; Ger T. Rijkers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dexamethasone Treatment Has No Effect on the Formation of Pneumococcal Antibodies during Community-Acquired Pneumonia

Author(s) -

Suzan P. van Mens,

Sabine C A Meijvis,

Jan C. Grutters,

Bart J. M. Vlaminckx,

Willem Jan W. Bos,

Ger T. Rijkers

Publication year - 2012

Publication title -

clinical and vaccine immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.649

H-Index - 77

eISSN - 1556-6811

pISSN - 1556-679X

DOI - 10.1128/cvi.05697-11

Subject(s) - dexamethasone , community acquired pneumonia , pneumococcal pneumonia , pneumonia , placebo , medicine , antibody , streptococcus pneumoniae , immunology , immune system , biology , antibiotics , microbiology and biotechnology , pathology , alternative medicine

In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research